The advance of AI allows doctors ‘to see’ dangerous blood clots that are formed
AI technology could be used to detect potentially mortal blood clots before attacking.
According to scientists from the University of Tokyo, who say they have created an unbeatized way of observing the blood coagulation activity as it occurs.
The new artificial intelligence tool uses a powerful microscope to monitor platelets in real time, researchers shared in a university press release.
What is artificial intelligence (AI)?
Platelets, which are small blood cells that help form clots to stop bleeding, play a “crucial role” in heart disease, particularly coronary artery disease, according to Dr. Kazutoshi Hirose, lead author of the study.
If the platelet count is too high, it can increase the risk of blood clots.
Scientists from the University of Tokyo have discovered an unavasive way of observing the blood coagulation activity as it occurs. (Istock)
To prevent hazardous clots, patients with coronary artery disease are generally treated with antiglagraphic drugs.
“However, it is still difficult to evaluate precisely how well these medications are working in each individual, which makes the monitoring of platelet activity an important objective for both doctors and researchers,” said Hirose in the press release.
How the tool works
Traditional monitoring methods of platelet activity often depend on indirect measurements or invasive procedures.
With the AI tool, a high -power microscope works as a “high -speed Super chamber that takes acute flows of flow blood cells,” said Yuqi Zhou, a chemistry assistant professor at the University of Tokyo, in the launch.
Artificial intelligence transforms patient care and reduces exhaustion, says the doctor
“Like traffic cameras, each car on the road, our microscope captures thousands of moving blood cells every second,” he said. “Then we use artificial intelligence to analyze those images.”
The AI can distinguish between a single platelet (“like a car”), a platelet group (“like a traffic jam”), or even a white blood cell that appears (“as a police car trapped in the jam”), Zhou described.
“At this time, doctors often give blood grain medicines and expect them to be working. With this method, they could actually see if the treatment is working.”
“This technology stands out because it allows doctors to directly observe platelets in the bloodstream and measure how groups interact and form groups in real time,” said Keisuke God, professor at the Department of Chemistry at the University of Tokyo, in the statement.
“Our studies have shown that it is highly effective in patients with coronary heart disease, the most common cause of heart attacks and one of the main causes of death in the United States and the world,” he added.
According to researchers, traditional methods to monitor platelet activity often depend on indirect measurements or invasive procedures. (Istock)
When the researchers tested the technique in more than 200 patients, they discovered that people with more serious heart problems had more agglomerate in the blood.
A blood sample taken from the arm of a patient and tested with the tool resulted in almost the same results as the blood taken directly from the arteries of the heart, they said.
Treatment implications
Harvey Castro, an emergency doctor and A -Headquarters expert in Texas, described the implications as significant for patient care.
“Today, we trust indirect laboratory markers or invasive blood raffles of the Cath laboratory to judge the risk of clot,” said Castro, who did not participate in the study, News Digital.
Click here to get the News application
“This technology turns an ordinary attractiveness into the live telemetry of platelet behavior, giving answers in seconds instead of hours.”
These advances have the potential to change the care standard for patients with coronary heart disease, according to researchers.
Click here to register in our health newsletter
“In general, if doctors want to understand what is happening in the arteries, especially in coronary arteries, they must do invasive procedures, such as inserting a catheter through the wrist or groin to collect blood,” said Hirose.
In the studies of the effectiveness of the tool, a regular blood analysis of the arm showed almost the same results as the blood taken directly from the arteries of the heart. (Istock)
“What we found is that taking a regular blood sample of a vein on the arm can still provide significant information about platelet activity in the arteries.”
For more health articles, visit www.Newsnews.com/health
God agreed that the tool could allow safer and personalized treatments for patients with heart disease.
“At this time, doctors often give drugs with blood and hope they are working,” he said. “With this method, they could see if the treatment works in each patient.”
Potential limitations
Castro warned that technology is not yet ready for generalized use.
“The microscope is avant -garde research team, it is not yet a header device,” he told News Digital. “We need miniaturization and cost falls before each ER can use it.”
“What we found is that taking a regular blood sample of a vein on the arm can still provide significant information about platelet activity in the arteries.” (Istock)
Looking towards the future, after greater research, Castro imagines that this innovation could change the decision -making decision for patients.
“Within five years, I can imagine a point of attention that allows me to adjust the antiplatelet drugs and how the oxygen titled quickly and safely for the patient in front of me,” he said.
Replace is a lifestyle production assistant with News Digital. She and the lifestyle team cover a variety of stories issues that include food and drink, travel and health.